Nanotechnology to fight cancer: From diagnosis to therapy
Due to their unique physico-chemical properties, nanomaterials are suited for visualization of tumors just as for therapy of cancer. During the 4th conference on “Current Trends in Cancer Theranostics (CTCT)” from July 1st to 5th in Lithuania, international scientists present new materials and their application in biomedical imaging.
For the fourth time since 2015, more than 100 researchers and industry representatives from more than 20 countries come together to discuss new nanoparticle-based methods for cancer therapy and diagnostics, also known as theranostics. The thematic focus is on new materials for specific labelling of tumor and drug release, novel imaging methods for cancer diagnostics and nanotechnologies for cancer therapy.
Dr. Vladimir Sivakov, head of a work group at Leibniz-IPHT and program chair of the CTCT conference, is pleased by the successful continuation of the event: “By bringing together scientist from different disciplines and linking them with partners from industry, we promote a targeted transfer of knowledge and technology. Thereby we aim to improve the recent options for diagnosis and treatment. This will enable doctors to detect cancer at a very early stage and to further develop a personalized cancer therapy. It is our objective to translate results from research more efficiently to clinical application.”, says Sivakov.
This year’s conference, which is organized by the National Cancer Institute and Vilnius University in Lithuania as well as by the Leibniz-Institute of Photonic Technology Jena (Leibniz-IPHT), will be the platform for the meeting of the “European Upconversion Network“ (funded by the European Union within in the program European Cooperation in Science and Technology – COST), the project “Carbon Nanomaterials for Cancer Theranostics” (funded by the European Union within the frame of the Marie Skłodowska-Curie Research and Innovation Staff Exchange – MCSA-RISE) and the Baltic Sea Network „NanoPhoto“.
(Deutsch) Weitere Informationen: